HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Indications for apheresis as an ultima ratio treatment of refractory hyperlipidemias.

Abstract
Lipid apheresis is at present well established in routine treatment of diverse hyperlipoproteinemias refractory to conventional dietary and medical regimens, especially in countries with high medical and socioeconomic standards. Severe familial hypercholesterolemia with atherosclerotic vessel disease involving the coronary arteries is the most frequent indication for lipid apheresis as well as homozygous familial hypercholesterolemia before the development of cardiovascular complications.In hyperlipoproteinemia (a) with progressive vessel disease, lipid apheresis is regularly accepted in Germany. The indication of apheresis in Refsum's disease and the chylomicronemia syndrome is described.
AuthorsP Grützmacher, C Kleinert, C Dorbath, B Öhm
JournalClinical research in cardiology supplements (Clin Res Cardiol Suppl) Vol. 10 Pg. 2-7 (Apr 2015) ISSN: 1861-0714 [Electronic] Germany
PMID25686595 (Publication Type: Journal Article)
Chemical References
  • Lipoprotein(a)
Topics
  • Blood Component Removal (methods)
  • Chronic Disease
  • Humans
  • Hyperlipoproteinemias (blood, diagnosis, prevention & control)
  • Lipoprotein(a) (blood, isolation & purification)
  • Patient Selection
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: